- Home
- BW vs ONCY Comparison
BW vs ONCY Comparison
Compare BW & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BW
- ONCY
- Stock Information
- Founded
- BW 1867
- ONCY 1998
- Country
- BW United States
- ONCY Canada
- Employees
- BW N/A
- ONCY N/A
- Industry
- BW Building Products
- ONCY Pharmaceuticals and Biotechnology
- Sector
- BW Industrials
- ONCY Health Care
- Exchange
- BW Nasdaq
- ONCY Nasdaq
- Market Cap
- BW 45.3M
- ONCY 49.1M
- IPO Year
- BW N/A
- ONCY 1999
- Fundamental
- Price
- BW $0.84
- ONCY $0.35
- Analyst Decision
- BW Buy
- ONCY Strong Buy
- Analyst Count
- BW 2
- ONCY 4
- Target Price
- BW $3.50
- ONCY $4.33
- AVG Volume (30 Days)
- BW 1.8M
- ONCY 847.4K
- Earning Date
- BW 05-12-2025
- ONCY 05-14-2025
- Dividend Yield
- BW N/A
- ONCY N/A
- EPS Growth
- BW N/A
- ONCY N/A
- EPS
- BW N/A
- ONCY N/A
- Revenue
- BW $734,239,000.00
- ONCY N/A
- Revenue This Year
- BW $9.70
- ONCY N/A
- Revenue Next Year
- BW $10.16
- ONCY N/A
- P/E Ratio
- BW N/A
- ONCY N/A
- Revenue Growth
- BW 12.90
- ONCY N/A
- 52 Week Low
- BW $0.22
- ONCY $0.33
- 52 Week High
- BW $2.99
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- BW 61.11
- ONCY 25.67
- Support Level
- BW $0.68
- ONCY $0.33
- Resistance Level
- BW $0.79
- ONCY $0.45
- Average True Range (ATR)
- BW 0.10
- ONCY 0.04
- MACD
- BW 0.00
- ONCY -0.01
- Stochastic Oscillator
- BW 59.41
- ONCY 8.10
About BW Babcock & Wilcox Enterprises Inc.
Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.